Hereditary neuropathy with liability to pressure palsies (HNPP): Intrafamilial phenotypic variability and early childhood refusal to walk as the presenting symptom.
Hereditary neuropathy with liability to pressure palsies (HNPP)
PMP22
The limping child
Journal
Italian journal of pediatrics
ISSN: 1824-7288
Titre abrégé: Ital J Pediatr
Pays: England
ID NLM: 101510759
Informations de publication
Date de publication:
03 Jun 2022
03 Jun 2022
Historique:
received:
16
08
2021
accepted:
13
05
2022
entrez:
6
6
2022
pubmed:
7
6
2022
medline:
9
6
2022
Statut:
epublish
Résumé
Limping and/or refusal to walk is a common complaint in the setting of the pediatric department, with a widely diverse differential diagnosis. An unusual etiology, is that of a hereditary neuropathy. Hereditary neuropathy with liability to pressure palsies (HNPP) is a recurrent, episodic demyelinating neuropathy, most commonly caused by a 17p11.2 chromosomal deletion encompassing the PMP22 gene. We pursued chromosomal microarray analysis (CMA) in multiple affected individuals of a single extended family, manifesting a range of phenotypic features consistent with HNPP. A 4.5 years-old boy presented for in-patient evaluation due to refusal to walk. Initial investigations including spine MRI and bone scan failed to yield a conclusive diagnosis. Following family history, which implied an autosomal dominant mode of inheritance, CMA was pursued and confirmed a 17p11.2 deletion in the proband consistent with HNPP. Importantly, following this diagnosis, four additional affected family members were demonstrated to harbor the deletion. Their variable phenotypic features, ranging from a prenatal diagnosis of a 6 months-old sibling, to recurrent paresthesias manifesting in the fourth decade of life, are discussed. Our experience with the family reported herein demonstrates how a thorough anamnesis can lead to a rare genetic etiology with a favorable prognosis and prevent unnecessary investigations, and underscores HNPP as an uncommon diagnostic possibility in the limping child.
Sections du résumé
BACKGROUND
BACKGROUND
Limping and/or refusal to walk is a common complaint in the setting of the pediatric department, with a widely diverse differential diagnosis. An unusual etiology, is that of a hereditary neuropathy. Hereditary neuropathy with liability to pressure palsies (HNPP) is a recurrent, episodic demyelinating neuropathy, most commonly caused by a 17p11.2 chromosomal deletion encompassing the PMP22 gene.
METHODS
METHODS
We pursued chromosomal microarray analysis (CMA) in multiple affected individuals of a single extended family, manifesting a range of phenotypic features consistent with HNPP.
RESULTS
RESULTS
A 4.5 years-old boy presented for in-patient evaluation due to refusal to walk. Initial investigations including spine MRI and bone scan failed to yield a conclusive diagnosis. Following family history, which implied an autosomal dominant mode of inheritance, CMA was pursued and confirmed a 17p11.2 deletion in the proband consistent with HNPP. Importantly, following this diagnosis, four additional affected family members were demonstrated to harbor the deletion. Their variable phenotypic features, ranging from a prenatal diagnosis of a 6 months-old sibling, to recurrent paresthesias manifesting in the fourth decade of life, are discussed.
CONCLUSIONS
CONCLUSIONS
Our experience with the family reported herein demonstrates how a thorough anamnesis can lead to a rare genetic etiology with a favorable prognosis and prevent unnecessary investigations, and underscores HNPP as an uncommon diagnostic possibility in the limping child.
Identifiants
pubmed: 35658923
doi: 10.1186/s13052-022-01280-z
pii: 10.1186/s13052-022-01280-z
pmc: PMC9164845
doi:
Substances chimiques
Myelin Proteins
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
84Informations de copyright
© 2022. The Author(s).
Références
Pediatr Clin North Am. 2020 Feb;67(1):119-138
pubmed: 31779828
J Neurol Neurosurg Psychiatry. 2013 Apr;84(4):392-7
pubmed: 23243264
Pediatr Neurol Briefs. 2015 Nov;29(11):83
pubmed: 26933540
Neuromuscul Disord. 1997 Dec;7(8):529-32
pubmed: 9447611
Neuromuscul Disord. 2019 Jun;29(6):422-426
pubmed: 31122831
Mol Neurobiol. 2013 Apr;47(2):673-98
pubmed: 23224996
Int J Immunopathol Pharmacol. 2012 Apr-Jun;25(2):513-7
pubmed: 22697084
Dtsch Arztebl Int. 2018 Feb 9;115(6):91-97
pubmed: 29478438
Hum Mutat. 2010 Dec;31(12):1326-42
pubmed: 20848651
Neuromuscul Disord. 2015 Sep;25(9):693-8
pubmed: 26189194
Neuropediatrics. 2020 Jun;51(3):173-177
pubmed: 31784971
Genet Med. 2005 Jul-Aug;7(6):422-32
pubmed: 16024975
J Clin Neuromuscul Dis. 2002 Mar;3(3):106-12
pubmed: 19078663
Pediatr Neurol. 1999 Nov;21(5):818-21
pubmed: 10593673